E S Daar

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, University of California, Los Angeles, USA
    Ann Intern Med 134:25-9. 2001
  2. ncbi Virology and immunology of acute HIV type 1 infection
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90048, USA
    AIDS Res Hum Retroviruses 14:S229-34. 1998
  3. ncbi Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. Hemophilia Growth and Development Study
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Department of Medicine, and the University of California Los Angeles School of Medicine, 90048, USA
    J Acquir Immune Defic Syndr 21:317-25. 1999
  4. ncbi Relation between HIV-1 and hepatitis C viral load in patients with hemophilia
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Division of Infectious Diseases, Department of Medicine, Los Angeles, CA 90048, USA
    J Acquir Immune Defic Syndr 26:466-72. 2001
  5. ncbi Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Division of Infectious Diseases, B217, Department of Medicine, and University of California Los Angeles School of Medicine, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    J Infect Dis 183:589-95. 2001
  6. ncbi Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infection
    M Lagnese
    Division of HIV Medicine and Infectious Diseases at Harbor UCLA Medical Center, Los Angeles, CA, USA
    Int J STD AIDS 22:463-4. 2011
  7. ncbi Reduced antiretroviral drug susceptibility among patients with primary HIV infection
    S J Little
    Department of Medicine, University of California, San Diego, USA
    JAMA 282:1142-9. 1999
  8. ncbi Seminal plasma HIV levels in men with asymptomatic sexually transmitted infections
    G Rieg
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center and the David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Int J STD AIDS 21:207-8. 2010
  9. ncbi Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells
    D N Forthal
    Division of Infectious Diseases, Department of Medicine, University of California, Irvine College of Medicine, Irvine, California, USA
    J Virol 75:6953-61. 2001
  10. ncbi Hepatitis C virus infection and neurocognitive function
    M Soogoor
    Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, CA, USA
    Neurology 67:1482-5. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, University of California, Los Angeles, USA
    Ann Intern Med 134:25-9. 2001
    ..The optimal approach for diagnosing primary HIV-1 infection has not been defined...
  2. ncbi Virology and immunology of acute HIV type 1 infection
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90048, USA
    AIDS Res Hum Retroviruses 14:S229-34. 1998
    ..Investigations of what constitutes an effective immune response to HIV will be vital to the success of vaccine development in the future...
  3. ncbi Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. Hemophilia Growth and Development Study
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Department of Medicine, and the University of California Los Angeles School of Medicine, 90048, USA
    J Acquir Immune Defic Syndr 21:317-25. 1999
    ..059). We conclude that plasma HIV RNA, CD4+ T lymphocytes, and CCR genotypes are correlated, and the protective affect of CCR2b against HIV disease progression is not completely explained by plasma HIV RNA or CD4+ T-lymphocyte number...
  4. ncbi Relation between HIV-1 and hepatitis C viral load in patients with hemophilia
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Division of Infectious Diseases, Department of Medicine, Los Angeles, CA 90048, USA
    J Acquir Immune Defic Syndr 26:466-72. 2001
    ..These results demonstrate that HIV-1/HCV co-infection is associated with a reduced likelihood of HCV clearance and that higher levels of HCV RNA are associated with increased hepatic inflammation...
  5. ncbi Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs
    E S Daar
    Cedars Sinai Burns and Allen Research Institute, Division of Infectious Diseases, B217, Department of Medicine, and University of California Los Angeles School of Medicine, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    J Infect Dis 183:589-95. 2001
    ..10-2.51; P=.016) and an RR for AIDS-related mortality of 1.54 (95% CI, 1.03-2.30; P=.036). These findings emphasize the need for further research regarding the use of HIV-1- and HCV-specific therapy in coinfected individuals...
  6. ncbi Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infection
    M Lagnese
    Division of HIV Medicine and Infectious Diseases at Harbor UCLA Medical Center, Los Angeles, CA, USA
    Int J STD AIDS 22:463-4. 2011
    ..01); relative risk 0.72 (95% confidence interval [CI] 0.57-0.92). Since HSV-2 seroprevalence is lower in those newly HIV-infected, the diagnosis of early HIV infection may allow for counselling to reduce subsequent HSV-2 acquisition...
  7. ncbi Reduced antiretroviral drug susceptibility among patients with primary HIV infection
    S J Little
    Department of Medicine, University of California, San Diego, USA
    JAMA 282:1142-9. 1999
    ..The transmission of drug-resistant human immunodeficiency virus (HIV) has been documented, but the prevalence of such transmission is unknown...
  8. ncbi Seminal plasma HIV levels in men with asymptomatic sexually transmitted infections
    G Rieg
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center and the David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Int J STD AIDS 21:207-8. 2010
    ..One patient who was not taking antiretrovirals had a 94% decline in SPVL after treatment of asymptomatic Chlamydia trachomatis urethritis, suggesting that asymptomatic infection may be a co-factor for HIV transmission...
  9. ncbi Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells
    D N Forthal
    Division of Infectious Diseases, Department of Medicine, University of California, Irvine College of Medicine, Irvine, California, USA
    J Virol 75:6953-61. 2001
    ..HIV-1-specific antibody may be an important contributor to the early control of HIV viremia...
  10. ncbi Hepatitis C virus infection and neurocognitive function
    M Soogoor
    Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Los Angeles, CA, USA
    Neurology 67:1482-5. 2006
    ..After controlling for multiple factors, HCV monoinfection was not associated with deficits in adaptive behavior, intelligence, or attention/concentration...
  11. ncbi High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates
    E S Daar
    Department of Medicine, Cedars Sinai Medical Center, University of California, Los Angeles School of Medicine 90048
    Proc Natl Acad Sci U S A 87:6574-8. 1990
    ..We conclude that unlike laboratory strains, primary HIV-1 isolates require high concentrations of sCD4 for neutralization. This phenomenon may pose a formidable problem for sCD4-based therapeutics in the treatment of HIV-1 infection...